Effect of supplementation in treatment of polycystic ovary syndrome

Not Applicable

• Conditions: Polycystic ovary syndrome.; Sclerocystic ovary syndrome Stein-Leventhal syndrome; E28.2

• Registration Number: IRCT201306085623N8
• Lead Sponsor: Vice chancellor for research, Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 81

Inclusion Criteria

Women aged 18-40 years diagnosed with PCOS

Exclusion Criteria

Women aged<18 or >40 years
Those with BMI<25 kg/m2, individuals with neoplastic, hepatic, renal and cardiovascular disorders
Malabsorptive disorders
Current or previous (within the last 6 months) use of hormonal
Antidiabetic medications
Anti-obesity medications
Intention to adopt a diet and/or a specific physical activity program

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Insulin. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Elisa.;Hs-CRP. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Elisa.